Pulmonary Delivery of Resveratrol-Loaded Nanocomposite Microparticles to Treat Lung Cancer

    January 2020
    Ashley George Muller
    Studysummary This study found that resveratrol-loaded polymeric nanoparticles show promise as a pulmonary drug delivery system for lung cancer, reducing resveratrol's IC50 significantly in Calu 3 cells.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on researchonline.ljmu.ac.uk →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia JAMA Dermatology · 2019
    2. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study ˜The œoncologist · 2018
    3. Pathogenesis and Treatment Options for Chemotherapy-Induced Alopecia: A Systematic Review International Journal of Dermatology · 2018

    Related research 1

    1. Paclitaxel-Loaded Star-Shaped Copolymer Nanoparticles for Enhanced Malignant Melanoma Chemotherapy Against Multidrug Resistance Drug Design Development and Therapy · 2017